Proteomics

Dataset Information

0

Administration of recombinant HSP47 as a new therapeutic approach to stimulate collagen secretion and ameliorate ECM in osteogenesis imperfecta


ABSTRACT: Collagen misfolding, reduced collagen secretion and incorporation into the extracellular matrix, and impaired collagen organization are common features both in a physiological condition like aging and in pathological conditions like genetic diseases caused by defects in collagen or collagen related genes. Osteogenesis imperfecta (OI) is the prototype of collagen disorders since it is mainly caused by mutations in genes responsible for the synthesis and post translational modification of collagen type I, the most abundant protein of our body and of our skeleton. OI probands show reduced bone mass, bone deformations, and increased bone fragility associated to frequent fractures, but they do not benefit from specific treatments. Here the therapeutic potential of heat shock protein 47 (HSP47), the collagen specific chaperone and a key endogenous player in collagen secretion, was tested in OI probands primary fibroblast lines. Administration of exogenous HSP47, that is able to be uptaken by the cell and to localize with both cis Golgi and secretory pathway sites, increased collagen secretion, reduced intracellular procollagen I retention and ameliorated the general ER proteostasis, leading to a substantial improvement in cellular homeostasis and vitality. These positive changes were also mirrored by an increased content into the OI proband matrix of collagen I. Efficacy of exogenous HSP47 was then proved in vivo on the bone phenotype of the zebrafish p3h1-/- OI model. Methods Collection samples nLC‑MS/MS analysis was used to assess hydroxylation and O-Glycosylation on lysine sites of type I collagen. Extracted collagen from control, OI and HS47 probands fibroblasts were separated by SDS-PAGE and stained with colloidal Coomassie; the bands α(I) and α(II) (i.e., at the selected molecular mass values) were excised and destained in 0.1% TFA: ACN 1:1 (v/v).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Simona Nonnis  

LAB HEAD: Elisa Maffioli

PROVIDER: PXD047320 | Pride | 2025-05-06

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Bianco_PZ_HSP47_collagen_alpha1.raw Raw
CTR_collagen_alpha1.raw Raw
CTR_collagen_alpha2.raw Raw
PZ_HSP47_collagen_alpha2.raw Raw
PZ_collagen_alpha1.raw Raw
Items per page:
1 - 5 of 11
altmetric image

Publications


The proof of principle of the therapeutic potential of heat shock protein 47 (HSP47) for diseases characterized by defects in collagen I synthesis is here demonstrated in osteogenesis imperfecta (OI), a prototype of collagen disorders. Most of the OI mutations delay collagen I chain folding, increasing their exposure to posttranslational modifications that affect collagen secretion and impact extracellular matrix fibril assembly. As a model, we used primary fibroblasts from OI individuals with a  ...[more]

Similar Datasets

2018-08-29 | PXD010041 | Pride
2024-03-22 | GSE261941 | GEO
2010-09-12 | E-TABM-761 | biostudies-arrayexpress
2019-08-22 | GSE129612 | GEO
2022-02-16 | PXD020346 | Pride
2024-07-25 | PXD044039 | Pride
2019-10-28 | PXD013450 | Pride
2020-09-16 | PXD015015 | Pride
2021-07-10 | PXD020462 | Pride
2025-03-24 | PXD048810 | Pride